New drug shows promise for rare Muscle-Wasting disease in men

NCT ID NCT06411912

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 25 times

Summary

This study tested an experimental drug called NIDO-361 in 54 men with spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease. The goal was to see if the drug is safe and can help maintain or increase muscle mass. Participants received either the drug or a placebo for up to 12 months, and researchers measured changes in muscle volume and tracked any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL AND BULBAR MUSCULAR ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Azienda Ospedale Università di Padova

    Padova, Italy

  • IRCCS Istituto Neurologico Carlo Besta

    Milan, Italy

  • Kyungpook National University Chilgok Hospital

    Daegu, South Korea

  • Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center

    Copenhagen, Denmark

  • University of College London Hospital (UCLH)

    London, United Kingdom

Conditions

Explore the condition pages connected to this study.